This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MYELODYSP_SYNDR_EXALLC for full statistics.
Myelodysplastic syndrome
C3_MYELODYSP_SYNDR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
298 |
4. Check minimum number of eventsNone |
298 |
5. Include endpointsNone |
298 |
6. Filter based on genotype QC (FinnGen only) |
298 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Myelodysplastic syndrome
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia and myelodysplastic syndromes
- Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)
- Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 298 | 106 | 192 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.08 |
| Median age at first event (years) | 76.91 | 78.03 | 76.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 274
- Matched controls
- 2741
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
193.4
162
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
569.3
193.0
171
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
47.4
117.8
146
64
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
442.2
115.6
108
*
XW000
NOMESCO Finland
Bone marrow biopsy
45.0
111.1
139
61
D64.9
ICD-10 Finland
Anaemia, unspecified
16.3
84.3
160
217
WW500
NOMESCO Finland
Blood transfusion
32.3
83.6
113
58
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
860.2
70.3
66
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
45.0
42
*
B03XA02
ATC
darbepoetin alfa; parenteral
29.7
43.7
59
25
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
253.6
43.2
43
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
+∞
39.5
37
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
113.1
36.8
39
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
29.5
36.4
49
20
A04AA01
ATC
ondansetron; systemic, rectal
12.4
31.6
59
59
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.6
29.6
37
11
L03AA02
ATC
filgrastim; parenteral
20.2
28.6
43
25
B03XA01
ATC
erythropoietin; parenteral
28.3
27.4
37
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
149.0
26.1
27
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
68.4
22.2
25
*
127
Kela drug reimbursment
Transplant complication
31.0
21.4
28
10
D70.89
ICD-10 Finland
Neutropenic splenomegaly
31.0
21.4
28
10
A05AA02
ATC
ursodeoxycholic acid; oral
37.3
19.2
24
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
19.0
18
*
L04AD01
ATC
ciclosporin; systemic
23.8
18.6
26
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
17.9
78
239
9982/3-C42.1
ICD-O-3
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia of bone marrow
+∞
16.8
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.8
16.7
32
33
ZX112
NOMESCO Finland
Subcutaneous
13.4
16.3
28
23
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.4
15.8
35
47
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
60.1
15.0
17
*
ZX120
NOMESCO Finland
Intravenous
4.5
14.1
52
134
WW200
NOMESCO Finland
Immunization
17.4
13.7
21
13
1BC07
NOMESCO Finland
NA
+∞
13.6
13
*
J02AC03
ATC
voriconazole; systemic
+∞
13.6
13
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
42.3
13.3
16
*
R50.9
ICD-10 Finland
Fever, unspecified
3.5
13.2
68
235
9985/3-C42.1
ICD-O-3
Myelodysplastic syndrome with multilineage dysplasia of bone marrow
+∞
12.6
12
*
9980/3-C42.1
ICD-O-3
Myelodysplastic syndrome with single lineage dysplasia of bone marrow
+∞
12.6
12
*
B82
ICPC
Anaemia other/unspecified
8.2
12.2
27
36
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
11.5
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
D46.4
ICD-10 Finland
Refractory anaemia, unspecified
+∞
11.5
11
*
Z51.5
ICD-10 Finland
Palliative care
4.2
11.5
45
122
SPAT1088
SPAT
Blood transfusion
26.3
11.3
15
6
L04AA06
ATC
mycophenolic acid; systemic
18.8
10.9
16
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.1
10.8
29
52
H02AB06
ATC
prednisolone; systemic
2.3
10.1
147
912
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
21.0
9.9
14
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.4
9.5
22
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
9.4
31
71
M04AA01
ATC
allopurinol; systemic
2.6
9.2
75
342
J01MA12
ATC
levofloxacin; systemic
2.5
8.8
76
359
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
92.7
8.5
9
*
V03AC03
ATC
deferasirox; oral
92.7
8.5
9
*
B73
ICPC
Leukaemia
92.7
8.5
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
8.4
32
85
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
8.4
8
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
8.3
27
61
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
8.2
98
540
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
8.1
120
729
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.8
8.1
11
5
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
8.0
28
69
J05AB11
ATC
valaciclovir; oral
3.1
7.9
45
165
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
7.5
53
221
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
41.1
6.8
8
*
B99
ICPC
Blood/lymph/spleen disease other
41.1
6.8
8
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.8
6.7
18
33
N02AA05
ATC
oxycodone; systemic
2.3
6.6
64
316
TGC00
NOMESCO Finland
Bronchial lavation
6.5
6.6
16
26
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
6.5
23
58
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
71.4
6.5
7
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
71.4
6.5
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.4
106
658
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
18.5
6.3
9
5
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
6.3
6
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
27.3
6.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.2
132
902
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
108
23
73.08
192.47
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
92
45
29.13
126.54
3.8
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
75
29
34.22
111.85
1.8
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
156
296
9.96
89.66
11.9
3.5
u/l
269.4
241.7
1.83
144
277
(3027945) Reticulocytes/100 erythrocytes in Blood
157
333
8.85
80.40
7.5
2.4
%
2.0
1.7
0.89
139
298
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
78
67
15.41
79.81
2.3
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
132
240
9.08
77.39
6.7
2.4
e9/l
76.1
65.6
0.38
108
200
(3004809) Band form neutrophils/100 leukocytes in Blood
57
39
17.84
65.68
10.8
3.6
%
1.6
0.7
1.65
44
33
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
134
9.64
65.56
2.4
1.7
g/l
1.0
1.6
8.05
78
119
(3017181) Myelocytes/100 leukocytes in Blood
96
181
7.35
52.52
13.5
3.7
%
2.0
0.7
2.01
67
66
(3017354) Segmented neutrophils/100 leukocytes in Blood
38
25
17.28
44.18
10.3
2.9
%
44.7
56.2
0.87
19
17
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
34
12.28
35.35
15.2
4.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
78
174
5.72
34.86
13.8
3.7
%
0.2
0.1
0.24
58
62
(3002179) Metamyelocytes/100 leukocytes in Blood
74
158
5.90
34.67
14.3
3.5
%
1.3
0.4
1.65
41
46
(3020630) Protein [Mass/volume] in Serum or Plasma
83
216
4.94
30.76
2.7
2.3
g/l
65.8
65.4
0.16
76
192
(42870588) Differential panel, method unspecified - Blood
159
667
3.97
30.75
25.2
5.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
62
8.15
30.54
3.4
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
31
27
12.70
30.52
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
29
23
13.86
30.18
1.3
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
75
183
5.14
29.97
2.5
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
10
22.52
27.90
1.2
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
22
13.40
27.60
1.3
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
31
5
68.85
27.53
2.9
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
30
11.01
26.93
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
21
13.47
26.69
1.3
1.1
u/ml
294.6
363.3
0.20
17
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
12
18.75
25.76
2.5
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
25
11.78
25.47
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
61
7.21
24.56
4.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
64
160
4.82
24.55
14.7
3.8
%
1.4
0.1
1.25
44
54
(3005719) IgG [Mass/volume] in Serum or Plasma
57
131
5.14
24.14
3.9
3.0
g/l
10.9
10.6
0.15
51
118
(40760888) Immunoglobulin light chains.free panel - Serum
35
51
7.64
23.44
2.9
3.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
22
17
13.89
23.08
1.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
22
17
13.89
23.08
1.5
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
104
5.44
22.65
2.1
1.8
g/l
3.7
3.7
0.12
31
74
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
105
5.39
22.41
2.1
1.8
g/l
6.1
7.5
5.89
31
76
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
105
5.39
22.41
2.1
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
48
7.61
22.11
4.0
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
95
5.54
21.89
1.4
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
41
77
6.01
21.56
2.6
2.8
ratio
9.5
1.4
—
5
7
(3034860) Kappa light chains.free [Mass/volume] in Serum
41
78
5.94
21.27
2.6
2.9
mg/l
70.1
172.0
0.59
36
59
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
40
78
5.77
20.20
2.6
2.9
mg/l
100.1
35.6
0.42
33
60
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
98
5.23
20.14
2.2
1.8
g/l
3.1
3.3
0.50
31
76
(3044640) Blood type and Crossmatch panel - Blood
144
698
3.06
19.90
19.0
2.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
168
889
3.04
19.78
24.1
5.4
%
0.7
0.6
0.73
158
829
(3006504) Eosinophils/100 leukocytes in Blood
170
914
3.00
19.30
25.0
5.3
%
2.0
2.8
1.95
160
846
(3022948) Iron [Moles/volume] in Serum or Plasma
100
400
3.26
19.18
2.5
2.4
umol/l
18.5
11.8
6.42
94
363
(3019069) Monocytes/100 leukocytes in Blood
170
920
2.97
18.96
26.8
5.6
%
11.1
9.0
2.53
160
858
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
16
12.62
18.87
2.6
2.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
171
934
2.95
18.66
26.2
5.6
%
32.2
25.0
6.22
160
858
(3026493) Urate [Moles/volume] in Serum or Plasma
122
561
2.99
18.20
5.6
2.9
umol/l
348.6
8217.7
2.96
115
456
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
25
9.42
17.88
5.7
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
40
7.32
17.72
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
89
350
3.20
17.36
2.5
2.4
%
37.3
21.5
6.09
73
303
(46235355) HIV 1 and 2 tests - Meaningful Use set
57
168
3.96
17.33
1.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
53
150
4.08
17.03
1.5
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
165
916
2.80
16.94
22.0
5.3
%
48.7
59.7
11.84
153
850
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
141
4.16
16.91
1.5
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
17
11.20
16.59
9.0
4.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
97
4.74
16.56
1.7
1.8
g/l
12.3
10.7
0.69
35
82
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
25
8.96
16.46
5.9
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
506
2.86
16.06
17.3
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
44
114
4.36
15.85
1.9
2.0
ug/l
7.9
3.6
0.23
33
98
(3019309) Folate [Moles/volume] in Red Blood Cells
119
574
2.79
15.83
2.3
1.8
nmol/l
1232.7
1149.6
0.34
91
420
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
39
6.91
15.63
1.5
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
14
12.02
15.44
6.4
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
14
12.02
15.44
6.4
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
14
12.02
15.44
6.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
14
12.02
15.44
6.4
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
166
957
2.66
15.32
30.1
4.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
6
33.66
14.99
1.9
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
38
92
4.59
14.89
2.4
1.9
g/l
1.7
0.5
0.43
33
78
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
55
176
3.61
14.74
2.9
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
79
316
3.04
14.72
7.2
4.7
mmol/l
1.1
1.0
0.72
74
288
(3001122) Ferritin [Mass/volume] in Serum or Plasma
149
827
2.60
14.70
5.3
2.7
ug/l
588.6
166.6
8.87
133
733
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
32
7.34
14.62
1.6
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
169
1001
2.59
14.48
22.4
5.2
e9/l
0.1
0.2
7.16
146
885
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
24
8.39
14.18
5.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
24
8.39
14.18
5.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
24
8.39
14.18
5.8
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
75
4.82
13.94
1.9
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
22
34
6.91
13.84
5.0
1.7
pg
33.0
32.7
0.08
22
34
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
31
7.21
13.76
1.4
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
163
977
2.48
13.23
20.4
5.2
e9/l
1.4
1.8
3.54
146
869
(3012095) Magnesium [Moles/volume] in Serum or Plasma
81
349
2.81
13.04
6.6
2.9
mmol/l
0.8
0.8
0.66
74
323
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
13
11.25
12.95
7.1
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
13
11.25
12.95
7.1
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
37
6.34
12.78
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
124
667
2.47
12.62
2.8
2.2
mg/l
3.3
3.2
0.08
105
564
(3023368) Bacteria identified in Blood by Culture
138
780
2.43
12.58
9.2
4.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
159
958
2.41
12.54
19.4
5.1
e9/l
0.7
0.6
0.15
142
834
(4035726)
53
183
3.31
12.53
1.9
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
14
10.44
12.32
7.1
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
35
6.38
12.30
1.6
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
159
964
2.39
12.29
19.4
5.1
e9/l
0.0
0.0
1.63
141
844
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
20
8.40
11.99
1.7
1.4
—
—
—
0
0
(44806118)
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
(44790048)
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
(44790049)
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
(44790047)
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
10
12.46
11.81
1.2
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
5
31.45
11.76
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
21
7.99
11.53
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
13
10.41
11.41
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
33
89
4.05
11.20
1.8
1.9
g/l
37.4
35.8
0.71
27
72
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
445
2.43
10.31
3.7
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
173
1144
2.22
10.21
38.3
8.2
e9/l
3.8
4.4
0.27
157
1013
(3008536) Aspergillus sp Ab [Presence] in Serum
11
11
10.34
9.60
5.8
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
9
0
+∞
9.42
1.0
0.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
17
7.95
9.35
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
59
4.34
9.17
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
78
386
2.38
9.13
17.6
4.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
71
338
2.44
9.04
1.8
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
13
18
7.51
8.91
9.3
1.8
e9/l
0.7
0.9
—
8
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
33
5.40
8.51
1.2
1.1
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
14
8.12
8.04
4.1
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
167
1160
2.00
7.86
18.0
5.5
umol/l
15.2
12.1
2.28
158
1084
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
21
6.43
7.78
1.2
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
12
8.59
7.62
2.5
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
12
8.59
7.62
2.6
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
73
381
2.21
7.40
3.1
1.9
s
30.6
29.8
0.29
68
366
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
153
1059
1.91
7.00
10.5
5.2
mmol/l
1.2
1.2
2.29
131
945
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
94
3.18
6.86
3.2
2.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
164
1168
1.90
6.81
12.1
6.0
mmol/l
1.2
1.2
1.53
131
964
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
302
2.24
6.59
2.3
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
304
2.17
6.10
2.5
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
9
11.44
5.83
2.5
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
9
11.44
5.83
2.5
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
59
311
2.12
5.74
1.3
1.4
g/l
2.3
2.9
0.95
46
183
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
46
3.86
5.73
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
24
578
0.36
5.68
3.0
3.2
ug/l
0.9
0.9
0.08
15
402
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
7
13.20
5.61
2.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
25
4.96
5.54
1.5
1.3
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
5
0
+∞
5.22
1.2
0.0
%
7.8
—
—
5
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
70
3.15
5.21
1.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
19
5.41
5.07
1.6
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
36
4.03
5.04
4.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
44
220
2.17
4.87
7.1
3.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
10
9.24
4.81
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
115
2.58
4.79
6.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
5
14.29
4.59
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
11
8.39
4.59
1.8
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
35
3.84
4.41
1.7
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
16
50
3.32
4.40
1.4
1.6
iu/ml
0.0
0.1
—
6
12
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
22
4.67
4.33
6.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
67
2.96
4.31
1.8
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
9
9.09
4.30
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
73
455
1.80
4.29
2.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
149
1851
0.61
4.25
4.0
5.4
mmol/l
2.0
2.5
7.78
122
1627
(3024561) Albumin [Mass/volume] in Serum or Plasma
139
1037
1.64
4.20
9.8
4.1
g/l
32.2
34.1
2.33
123
954
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
23
4.46
4.12
6.3
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
23
4.46
4.12
6.3
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
23
4.46
4.12
6.3
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
23
4.46
4.12
6.3
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
105
2.51
4.10
3.2
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
10
8.18
4.08
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
134
996
1.63
4.08
2.9
2.2
pmol/l
89.1
90.8
0.16
85
533
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
14
6.59
4.01
1.7
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
14
6.59
4.01
1.7
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
144
1792
0.62
4.00
6.2
6.8
mmol/mol
40.9
41.8
0.36
126
1619
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
24
4.28
3.92
6.3
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
77
2.71
3.89
2.7
1.9
u/ml
0.3
0.3
—
9
39
(40758558) Short blood count panel - Blood
76
493
1.73
3.86
30.4
5.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
61
2.89
3.75
1.6
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
9
7.93
3.57
1.0
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
50
794
0.56
3.57
3.7
4.6
%
24.3
21.7
0.50
22
417
(3018418) pH of Serum or Plasma
100
711
1.61
3.55
10.1
3.7
ph
7.4
7.4
1.33
17
145
(3028433) Virus identified in Specimen by Culture
8
13
6.29
3.52
1.6
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
27
518
0.47
3.49
2.4
3.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
70
2.67
3.45
3.6
3.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
27
3.80
3.38
1.9
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
145
1770
0.65
3.37
3.7
4.7
mmol/l
1.3
1.4
2.40
117
1557
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
147
1785
0.65
3.29
3.7
4.7
mmol/l
3.7
4.3
8.56
118
1592
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
7
8.71
3.27
17.5
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
204
1.93
3.17
1.4
1.3
titre
460.0
547.9
0.14
12
53
(3000012) Reticulocyte production index
8
16
5.11
3.07
2.3
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
8
7.62
3.07
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
149
1790
0.66
3.03
44.3
18.0
ml/min/173m2
74.1
69.5
1.98
124
1497
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
30
3.41
2.93
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
103
2.23
2.89
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
143
1718
0.68
2.79
4.0
4.2
mmol/l
1.2
1.2
0.30
118
1502
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
6
8.45
2.76
1.2
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
10
6.10
2.71
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
19
4.30
2.69
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
61
2.54
2.66
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
61
2.54
2.66
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
38
2.97
2.61
2.3
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
115
1428
0.68
2.59
5.3
4.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.24
2.56
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
7
7.24
2.56
1.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
16
4.45
2.49
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
12
5.08
2.41
2.8
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
36
2.84
2.22
15.1
2.4
%
56.6
60.9
—
10
36
(3047189) Immunofixation for 24 hour Urine
5
9
5.63
2.22
1.0
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
19
3.75
2.16
3.6
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
456
1.51
2.16
1.9
1.7
mg/l
2.4
1.5
1.12
52
366
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
162
1.80
2.11
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
20
3.56
2.06
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
15
4.06
2.05
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
21
113
1.92
1.97
3.3
3.7
mmol/l
24.2
24.1
0.06
21
102
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
111
893
1.39
1.95
3.4
3.3
ng/l
2992.6
2237.0
0.63
101
768
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
16
3.80
1.94
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
39
2.62
1.94
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
39
2.62
1.94
1.3
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
39
258
1.59
1.83
2.2
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
124
1.84
1.81
6.0
2.6
e9/l
5.4
4.2
0.32
14
82
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
33
212
1.63
1.74
2.1
2.1
g/l
0.2
0.2
0.61
28
192
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
13
3.89
1.72
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
79
993
0.72
1.70
4.5
5.5
ug/l
2.2
3.8
1.33
67
862
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
49
2.29
1.65
1.6
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
164
1847
0.75
1.65
5.2
5.1
mmol/l
6.2
6.2
0.03
130
1619
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
14
3.61
1.62
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
38
258
1.54
1.61
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
182
2016
0.75
1.60
28.3
10.8
u/l
24.3
23.6
0.23
169
1912
(3000494) Fungus identified in Specimen by Culture
36
243
1.55
1.56
3.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
178
1974
0.76
1.55
46.5
18.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
44
2.32
1.55
1.3
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
33
2.46
1.55
2.3
4.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
33
2.46
1.55
3.1
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
116
1.78
1.53
5.5
7.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
27
2.63
1.52
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
86
688
1.35
1.52
2.5
2.3
u/l
48.4
57.8
2.15
75
636
(3012516) Albumin [Mass/volume] in Urine
48
645
0.70
1.51
2.7
3.1
mg/l
1336.6
155.0
0.45
34
446
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
77
608
1.36
1.47
3.8
2.9
u/l
49.0
34.1
0.50
70
584
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
105
869
1.32
1.47
5.3
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
80
636
1.35
1.47
2.0
1.7
nmol/l
19.6
20.1
0.11
72
530
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
28
183
1.59
1.40
2.6
2.6
u/l
40.3
30.6
0.54
23
147
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
60
2.04
1.40
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
128
1.69
1.37
5.8
3.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
23
2.64
1.37
1.8
2.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
23
2.64
1.37
1.7
2.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
53
686
0.72
1.33
3.8
3.8
mg/mmol
16.2
10.7
0.28
34
456
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
162
1.59
1.31
2.5
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
49
640
0.72
1.30
2.8
3.1
mmol/l
6.3
7.1
0.74
40
521
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
62
1.97
1.29
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
62
1.97
1.29
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
53
403
1.38
1.28
18.1
31.2
inr
1.6
1.4
—
8
48
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
44
2.08
1.28
1.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
45
593
0.72
1.26
5.1
4.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
123
1058
1.28
1.26
7.2
11.7
inr
1.4
1.4
0.05
27
311
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
25
2.43
1.25
1.0
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
141
0.48
1.24
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
49
2.08
1.23
1.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
156
1734
0.79
1.22
4.8
4.6
mu/l
2.2
2.1
0.37
128
1494
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
19
2.66
1.22
1.8
1.4
%
54.4
70.8
—
5
12
(3051651) Icteric interference index of Serum or Plasma
5
19
2.66
1.22
3.4
4.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
34
243
1.45
1.16
3.3
3.6
mmol/l
1.2
1.8
0.28
28
188
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
35
0.00
1.16
0.0
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
201
1.49
1.15
4.6
3.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
193
2085
0.79
1.14
82.5
27.1
g/l
100.3
131.5
57.69
182
2029
(3035941) MCH [Entitic mass]
193
2085
0.79
1.14
80.8
26.8
pg
31.5
30.5
5.44
184
2033
(3026361) Erythrocytes [#/volume] in Blood
193
2085
0.79
1.14
81.2
26.9
e12/l
3.2
4.3
55.59
179
2003
(3010813) Leukocytes [#/volume] in Blood
193
2085
0.79
1.14
81.4
26.9
e9/l
8.2
7.0
0.40
180
2002
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
40
2.03
1.13
1.0
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
193
2084
0.79
1.13
81.1
26.8
fl
96.0
92.0
10.26
184
2033
(3007461) Platelets [#/volume] in Blood
193
2084
0.79
1.13
81.7
26.9
e9/l
157.8
234.6
12.21
178
2015
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
51
1.99
1.12
1.9
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
140
0.49
1.12
6.1
5.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
166
0.53
1.11
2.7
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
387
1.35
1.09
4.4
3.4
e6/l
2.3
2.0
0.10
29
230
(3045788) Cell count panel - Pleural fluid
7
34
2.08
1.03
1.4
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
151
1353
1.24
1.03
8.9
4.5
mmol/l
7.2
6.9
0.80
142
1271
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
30
0.00
0.98
0.0
2.9
—
52.3
—
0
30
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
26
183
1.46
0.97
5.7
3.6
kpa
5.4
5.1
0.57
19
165
(3044290) Cell count panel - Cerebral spinal fluid
6
27
2.25
0.94
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
192
2055
0.82
0.91
49.9
22.0
mmol/l
4.0
4.0
0.43
183
1985
(3026782) Osmolality of Urine
65
537
1.27
0.90
4.1
3.2
mosm/kgh2o
518.1
557.7
1.06
60
461
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
71
1.72
0.90
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
67
556
1.26
0.90
1.7
1.9
pmol/l
248000571.6
427.3
0.49
50
456
(3019550) Sodium [Moles/volume] in Serum or Plasma
192
2053
0.82
0.89
47.4
21.9
mmol/l
138.6
139.5
4.33
181
1981
(3036481) Cortisol [Moles/volume] in Serum or Plasma
26
187
1.43
0.88
2.7
1.7
nmol/l
322.1
370.5
0.51
26
163
(3000492) Spirometry study
8
138
0.57
0.85
1.8
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
25
181
1.42
0.83
5.5
3.7
—
7.4
—
0
18
(36304419) Bacteria [Presence] in Urine
73
619
1.24
0.81
5.2
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
69
810
0.81
0.81
5.8
5.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
33
1.83
0.79
2.0
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
307
1.31
0.79
4.8
5.5
mmol/l
1.0
1.4
0.16
31
241
(3008295) Osmolality of Serum or Plasma
0
27
0.00
0.78
0.0
1.1
—
273.3
—
0
15
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
482
1.25
0.77
3.9
3.9
ng/l
89.9
238.4
1.09
49
431
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
176
1634
1.19
0.74
22.7
7.0
u/l
79.5
80.2
0.09
164
1512
(3004616) Nuclear Ab [Presence] in Serum
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
268
1.30
0.69
13.3
8.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
28
1.80
0.66
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
28
1.80
0.66
3.4
4.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
30
235
1.31
0.64
2.3
2.7
ug/l
2.3
7.0
3.40
19
203
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
29
1.74
0.64
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
103
0.57
0.63
2.5
3.1
u/ml
10.2
1848.7
—
6
86
(3002582) Erythrocytes [#/volume] in Urine
86
762
1.18
0.61
5.2
3.6
e6/l
411.9
165.9
0.32
72
607
(3009261) Glucose [Presence] in Urine by Test strip
93
1035
0.85
0.61
5.3
4.6
estimate
0.0
0.0
0.00
14
206
(3014576) Chloride [Moles/volume] in Serum or Plasma
38
311
1.25
0.59
10.4
5.9
mmol/l
103.9
104.0
0.09
38
303
(3017569) Oxygen content in Arterial blood
0
23
0.00
0.58
0.0
4.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
23
0.00
0.58
0.0
4.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
1018
0.86
0.55
7.2
6.1
estimate
0.0
0.0
0.00
17
211
(3000850) Epithelial cells [#/volume] in Urine
62
539
1.19
0.55
3.8
2.8
e6/l
6.9
4.6
1.39
56
479
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
161
1.33
0.53
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
20
258
0.76
0.53
1.8
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
158
1486
1.13
0.48
5.4
4.3
mm/h
26.0
15.4
5.20
142
1335
(3024928) Oxygen saturation in Venous blood
7
46
1.53
0.48
1.6
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
46
1.53
0.48
1.7
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
93
1016
0.88
0.46
5.3
4.4
estimate
0.0
0.0
0.00
18
213
(3037467) Urinalysis macro (dipstick) panel - Urine
154
1451
1.13
0.45
6.7
4.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
51
1.38
0.44
1.1
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
94
862
1.13
0.42
40.4
10.5
e9/l
0.6
0.0
0.55
81
721
(3022806) Fractional oxyhemoglobin in Capillary blood
5
32
1.57
0.42
2.8
1.8
%
88.5
88.6
—
5
32
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
96
1.37
0.42
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
195
1.25
0.42
2.8
3.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
33
1.52
0.41
1.6
1.6
%
53.8
60.9
—
5
33
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
33
1.52
0.41
1.0
3.7
—
30.5
—
0
6
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
15
0.00
0.41
0.0
1.3
—
7.1
—
0
10
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
17
132
1.31
0.41
7.1
7.2
mmol/l
22.4
24.7
0.85
17
118
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
418.1
—
0
7
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
282.5
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
37.7
—
0
6
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
17
133
1.30
0.39
1.5
1.7
%
1.9
1.7
0.51
11
107
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
36
1.40
0.38
4.6
1.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
9
68
1.33
0.38
7.8
5.1
mmol/l
2.2
3.0
—
9
42
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
90
829
1.12
0.38
2.5
2.2
nmol/l
78.9
78.2
0.09
77
710
(3018095) Leukocytes [#/volume] in Urine
91
839
1.12
0.37
6.4
4.2
e6/l
101.0
208.2
0.60
74
641
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
254
1.20
0.37
7.0
4.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
244
0.81
0.36
1.2
1.3
u/ml
1.0
19.6
—
7
86
(36660697) Celiac disease serology panel - Serum
13
100
1.31
0.34
1.3
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
209
0.80
0.33
1.5
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
57
1.23
0.29
1.3
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
196
1.19
0.28
7.6
6.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
161
0.80
0.28
4.8
3.6
ml/min/173m2
53.9
54.7
—
7
72
(3030467) Casts [#/volume] in Urine by Automated count
72
669
1.10
0.26
5.4
3.5
e6/l
0.6
0.5
0.10
58
522
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
390
1.12
0.24
4.4
3.1
e6/l
0.8
1.1
0.35
22
230
(3026008) Bacteria identified in Urine by Culture
84
791
1.09
0.23
5.6
3.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
11
0.00
0.21
0.0
5.1
—
24.6
—
0
11
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
4.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
29.6
—
0
10
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
5.2
—
—
—
0
0
(4211845)
0
12
0.00
0.21
0.0
5.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
43
1.17
0.21
1.2
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
133
1375
0.94
0.18
4.0
3.7
pmol/l
14.9
15.2
0.41
112
1185
(3019150) Specific gravity of Urine by Refractometry
43
464
0.91
0.18
5.6
5.0
kg/l
1.0
1.0
—
6
83
(4010399)
12
142
0.84
0.18
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
114
1097
1.06
0.18
3.2
3.1
u/l
89.3
56.6
1.38
99
996
(3009542) Hematocrit [Volume Fraction] of Blood
165
1606
1.06
0.17
57.0
20.1
%
29.6
37.4
13.76
83
930
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
66
0.75
0.17
1.0
1.0
—
—
—
0
0
(4034850)
5
69
0.72
0.17
24.6
11.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
70
1.15
0.16
4.6
3.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
6
76
0.79
0.16
1.0
1.1
—
88.8
—
0
20
(3020891) Body temperature
12
102
1.18
0.15
5.6
4.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
140
1.15
0.15
3.8
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
191
1946
0.95
0.14
53.5
18.7
mg/l
33.0
27.8
0.97
177
1659
(1761482) Bacteria [#/volume] in Urine by Culture
8
100
0.79
0.14
4.9
5.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
109
0.82
0.13
2.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
24
261
0.91
0.12
1.0
1.2
iu/ml
18.0
45.1
—
5
82
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
81
840
0.95
0.12
2.9
2.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
104
1012
1.04
0.10
4.6
4.5
ng/l
30.0
44.3
1.89
82
803
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
449
1.06
0.09
5.5
4.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
6
58
1.04
0.08
1.7
1.3
mmol/l
51.8
60.1
—
6
52
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
61
0.82
0.08
2.2
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
57
590
0.96
0.08
5.6
4.6
estimate
0.0
0.0
0.00
13
202
(3043409) Potassium [Moles/volume] in Arterial blood
7
84
0.83
0.07
5.9
3.1
mmol/l
4.2
4.0
—
7
75
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
32
334
0.95
0.05
1.3
1.2
u/ml
7.2
1.5
—
8
85
(3013512) EKG study
71
726
0.97
0.05
4.9
4.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
120
0.91
0.05
2.3
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
78
766
1.02
0.04
3.4
3.1
mmol/l
2.3
2.3
2.03
63
658
(40768443) Skin Pathology biopsy report
11
102
1.08
0.03
1.5
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
187
0.96
0.01
5.9
3.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
69
698
0.99
0.01
1.8
2.1
u/l
95.8
383.7
1.97
62
653
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
261
1.00
0.00
2.2
4.2
ug/l
3.8
40.1
0.79
20
222
(40768804) Tissue Pathology biopsy report
76
761
1.00
0.00
2.4
2.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
265
1.02
0.00
3.9
4.8
%
36.6
32.2
0.61
13
166
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
79
1.01
0.00
1.5
1.2
u/ml
102.7
283.9
—
8
69
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
3.2
—
0
8
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
15.9
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
5
57
0.88
0.00
2.8
2.3
—
15.6
—
0
28
(3027008) Opiates [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.1
—
0
7
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
80.1
—
0
6
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
9.8
—
0
9
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MYELODYSP_SYNDR – Myelodysplastic syndrome
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).